Get the Stockscreener App
2.44
3.63%
-0.03
Mangoceuticals Inc stock is traded at $2.44, with a volume of 46,149.
It is down -3.63% in the last 24 hours and down -2.04% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$2.47
Open:
$2.42
24h Volume:
46,149
Relative Volume:
0.13
Market Cap:
$5.94M
Revenue:
-
Net Income/Loss:
$-7.32M
P/E Ratio:
-5.5746
EPS:
-0.4377
Net Cash Flow:
$-5.99M
1W Performance:
-0.40%
1M Performance:
-2.04%
6M Performance:
-69.20%
1Y Performance:
-71.06%
1-Day Range:
$2.38
$2.4699
1-Week Range:
$2.27
$2.47
52-Week Range:
$2.10
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| MGRX | 2.4058 | 5.94M | 0 | -7.32M | -5.99M | -0.4377 |
| VEEV | 213.72 | 33.92B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 69.47 | 11.55B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 49.00 | 9.32B | 493.63M | 160.55M | 162.20M | 0.55 |
| TEM | 54.10 | 9.04B | 640.44M | -743.28M | -206.93M | 0.00 |
| HQY | 103.10 | 8.87B | 1.10B | 105.67M | -197.98M | 0.1475 |
Mangoceuticals Inc Stock (MGRX) Latest News
Mangoceuticals Inc. (MGRX) Quarterly 10-Q Report - Quartzy
Mangoceuticals Signs Consulting Deal with CFO Johnston - TipRanks
Mangoceuticals (MGRX) versus Its Competitors Head-To-Head Contrast - Defense World
Financial Comparison: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Mangoceuticals (MGRX) and The Competition Head-To-Head Comparison - Defense World
Head to Head Survey: Mangoceuticals (MGRX) vs. The Competition - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Head-To-Head Analysis: Mangoceuticals (MGRX) vs. The Competition - Defense World
Mangoceuticals (MGRX) & Its Competitors Head to Head Comparison - Defense World
Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World
Financial Survey: Mangoceuticals (MGRX) & Its Competitors - Defense World
Mangoceuticals (MGRX) versus Its Peers Head to Head Comparison - Defense World
Mangoceuticals (MGRX) & Its Competitors Financial Analysis - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World
Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World
Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World
Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks
Analyzing Mangoceuticals (MGRX) and Its Competitors - Defense World
Mangoceuticals (MGRX) and Its Peers Financial Comparison - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & Its Peers - Defense World
Head to Head Analysis: Mangoceuticals (MGRX) vs. Its Competitors - Defense World
Financial Review: Mangoceuticals (MGRX) & Its Peers - Defense World
Comparing Mangoceuticals (MGRX) and Its Peers - Defense World
Mangoceuticals issues shares, raises $78,787 in capital By Investing.com - Investing.com South Africa
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) vs. NewGenIvf Group (NASDAQ:NIVF) - Defense World
Mangoceuticals issues shares, raises $78,787 in capital - Investing.com India
Reviewing Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) & Its Rivals Critical Comparison - Defense World
Comparing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals Responds to Claims Made by Eli Lilly in Recent Press Release - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Rivals - Defense World
Mangoceuticals explores strategic alternatives to boost shareholder value By Investing.com - Investing.com Australia
Mangoceuticals explores strategic alternatives to boost shareholder value - Investing.com
MangoRx Announces Formation of Strategy and Alternatives Committee - GlobeNewswire
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit - MSN
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit (NASDAQ:MGRX) - Seeking Alpha
Mangoceuticals Board Initiates Process to Evaluate Strategic Alternatives - Marketscreener.com
Mangoceuticals Defends Against Eli Lilly Allegations - TipRanks
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - ForexTV.com
MangoRx faces lawsuit from Eli Lilly over medication - Investing.com
Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide - TipRanks
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mangoceuticals Inc Stock (MGRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hamilton Alex P. | Director |
Jun 25 '24 |
Sale |
0.31 |
16,574 |
5,138 |
158,426 |
0.55%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):